Aardvark Therapeutics, Inc. Common Stock (AARD) financials · $284.4M cap
Aardvark Therapeutics, Inc. Common Stock (AARD) $284.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $0 | $2.4M |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$62.7M | -$22.8M |
| Net Income | -$57.6M | -$20.6M |
| EPS (Diluted) | $-2.93 | $-5.15 |
| Line | FY2025 |
|---|---|
| Total Assets | $117.2M |
| Current Assets | $111.9M |
| Cash & Equivalents | $47.1M |
| Inventory | $0 |
| PP&E | $0 |
| Total Liabilities | $10.5M |
| Current Liabilities | $10.5M |
| Short-term Debt | $0 |
| Long-term Debt | $0 |
| Total Debt | $0 |
| Shareholders' Equity | $106.6M |
| Retained Earnings | -$115.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$54.2M | -$18.1M |
| CapEx | $95.0K | $109.0K |
| Investing Cash Flow | -$49.7M | -$12.0M |
| Financing Cash Flow | $89.2M | $82.0M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $0 | $0 |
| Free Cash Flow | -$54.1M | -$18.0M |
FAQ
What is AARD P/E and revenue?
Aardvark Therapeutics, Inc. Common Stock (AARD) $284.4M cap.
What is AARD revenue?
Aardvark Therapeutics, Inc. Common Stock last cached revenue is $0 (FY2025).
Is AARD profitable?
Aardvark Therapeutics, Inc. Common Stock last cached net income is -$57.6M.
What are AARD total assets?
Aardvark Therapeutics, Inc. Common Stock last cached total assets are $117.2M.
What is AARD free cash flow?
Aardvark Therapeutics, Inc. Common Stock last cached free cash flow is -$54.1M.
Not investment advice. Cached statements, not a live tape.